DE60104442D1 - Neue galenische dispergierbare und lösliche paracetamol-zubereitung, methode zu deren herstellung und deren anwendungen - Google Patents

Neue galenische dispergierbare und lösliche paracetamol-zubereitung, methode zu deren herstellung und deren anwendungen

Info

Publication number
DE60104442D1
DE60104442D1 DE60104442T DE60104442T DE60104442D1 DE 60104442 D1 DE60104442 D1 DE 60104442D1 DE 60104442 T DE60104442 T DE 60104442T DE 60104442 T DE60104442 T DE 60104442T DE 60104442 D1 DE60104442 D1 DE 60104442D1
Authority
DE
Germany
Prior art keywords
dispersible
soluble
applications
production
granulate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60104442T
Other languages
English (en)
Other versions
DE60104442T2 (de
Inventor
Mart N Luis Carvajal
Asensio Juan Carlos Asensio
Tirado Francisco Javie Sevilla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Belmac SA
Original Assignee
Laboratorios Belmac SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Belmac SA filed Critical Laboratorios Belmac SA
Publication of DE60104442D1 publication Critical patent/DE60104442D1/de
Application granted granted Critical
Publication of DE60104442T2 publication Critical patent/DE60104442T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DE60104442T 2000-11-03 2001-10-24 Neue galenische dispergierbare und lösliche paracetamol-zubereitung, methode zu deren herstellung und deren anwendungen Expired - Lifetime DE60104442T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200002653 2000-11-03
ES200002653A ES2174734B1 (es) 2000-11-03 2000-11-03 Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.
PCT/ES2001/000402 WO2002036101A1 (es) 2000-11-03 2001-10-24 Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones

Publications (2)

Publication Number Publication Date
DE60104442D1 true DE60104442D1 (de) 2004-08-26
DE60104442T2 DE60104442T2 (de) 2005-09-15

Family

ID=8495530

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60104442T Expired - Lifetime DE60104442T2 (de) 2000-11-03 2001-10-24 Neue galenische dispergierbare und lösliche paracetamol-zubereitung, methode zu deren herstellung und deren anwendungen

Country Status (9)

Country Link
US (1) US6620433B2 (de)
EP (1) EP1331001B1 (de)
JP (1) JP2004512355A (de)
AT (1) ATE271378T1 (de)
DE (1) DE60104442T2 (de)
ES (1) ES2174734B1 (de)
PL (1) PL355106A1 (de)
PT (1) PT1331001E (de)
WO (1) WO2002036101A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114069D0 (en) 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
US6581767B2 (en) * 2001-08-20 2003-06-24 Wen-Chien Cheng Golf bag base
CA2523079C (en) * 2003-05-02 2012-08-14 Globopharm Pharmazeutische Produktions-Und Handelsgesellschaft M.B.H. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
CA2566384C (en) * 2004-05-28 2010-08-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
EP1954298A4 (de) * 2005-11-28 2012-10-31 Imaginot Pty Ltd Abgabesystem für eine orale therapeutische verbindung
KR101465647B1 (ko) * 2013-02-25 2014-11-27 김성호 가용성 타블렛형 청즙차의 제조방법
WO2015070396A1 (zh) * 2013-11-13 2015-05-21 财团法人国防教育研究基金会 无肝副作用的对乙酰胺基酚新复方组合
EP2987482A1 (de) 2014-08-22 2016-02-24 Santa Farma Ilaç Sanayi A.S. Lösliche und dispergierbare pharmazeutische Formulierung enthaltend Deferasirox
JP6858729B2 (ja) * 2018-05-25 2021-04-14 ▲財▼▲団▼法人国防教育研究基金会Ｎａｔｉｏｎａｌ Ｄｅｆｅｎｓｅ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 肝臓に対する副作用がない、新しいアセトアミノフェン複合組成

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092893B1 (de) * 1970-06-29 1973-07-13 Bru Jean
US4309408A (en) * 1978-11-16 1982-01-05 Beecham Group Limited Effervescent powders
CA1209040A (fr) 1982-12-21 1986-08-05 Jean Bru Procede de fabrication de granules et comprimes effervescents
US4942039A (en) 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
ES2060736T3 (es) * 1989-01-12 1994-12-01 Bayer Ag Composicion antiacida analgesica efervescente con un contenido en sodio reducido.
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
GB9601398D0 (en) * 1996-01-24 1996-03-27 Piper Edwina M Composition
DE69817189T2 (de) * 1998-11-23 2004-06-17 E-Pharma Trento S.P.A., Trento Ravina Verfahren zur Herstellung eines Brausegranulats
US6544557B2 (en) * 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions

Also Published As

Publication number Publication date
US6620433B2 (en) 2003-09-16
WO2002036101A1 (es) 2002-05-10
ATE271378T1 (de) 2004-08-15
PT1331001E (pt) 2004-11-30
PL355106A1 (en) 2004-04-05
EP1331001A1 (de) 2003-07-30
ES2174734B1 (es) 2003-10-01
JP2004512355A (ja) 2004-04-22
US20020197312A1 (en) 2002-12-26
EP1331001B1 (de) 2004-07-21
DE60104442T2 (de) 2005-09-15
ES2174734A1 (es) 2002-11-01

Similar Documents

Publication Publication Date Title
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
DK108192D0 (da) Farmaceutisk praeparat med langsom frigivelse og anvendelse af forbindelse til fremstilling af praeparatet
CA2396159A1 (en) Novel substituted benzimidazole dosage forms and method of using same
TR200500745T2 (tr) Damar gelişimi inhibitörleri olarak kuinazolin türevleri.
BR9503386A (pt) Formulaçao farmacêutica comprimido dispersivel e processo para a fabricaçao de comprimidos dispersíveis contendo cloridrato de fluoxetina
DE60138468D1 (de) Cyanophenoxy-carbonsäuren und zusammensetzungen für die freisetzung aktiver substanzen
HUP0302060A2 (hu) Eljárás készítmények elżállítására
GEP20053510B (en) Substituted Pyrrolopyridinone Derivatives Useful as Phosphodiesterase Inhibitors
AR015524A1 (es) FORMULACIoN ESTABLE DE SOLUCIoN DE OXIPLATINO, SU USO PARA LA MANUFACTURA DE UN MEDICAMENTO, PROCESO PARA SU PREPARACIoN, PRODUCTO FARMACÉUTICO QUE LA CONTIENE Y UN MÉTODO PARA ESTABILIZAR UNA SOLUCIoN DE OXALIPLATINO.
SI1341524T1 (sl) Farmacevtski pripravek v obliki paste, ki obsega kislinsko labilno učinkovino
HUP0000141A2 (hu) Eljárás legfeljebb 90 tömeg% gyógyhatású anyagot tartalmazó pelletek előállítására
DE60104442D1 (de) Neue galenische dispergierbare und lösliche paracetamol-zubereitung, methode zu deren herstellung und deren anwendungen
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter
BG106516A (en) Pharmaceutical agent comprising a benzamide derivative as active ingredient
DOP2001000130A (es) Sistema de administración oral controlada para la ingestión diaria de ciprofloxacina
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
SE0001916D0 (sv) Novel formulation
DE60103276D1 (de) Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
ATE408619T1 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzneimittel
DE50201005D1 (de) Verfahren zur herstellung von tabletten aus pflanzlichen extrakten
DE60009933D1 (de) Pharmazeutische zusammensetzung enthaltend trichloroessigsäure, 2-oh benzoesäure und menthol zur topischen anwendung und verfahren zu deren herstellung
DE60121142D1 (de) Zusammensetzung die paracetamol und niflumic säure enthält
NZ532449A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and Crohn's disease
JP2004051609A (ja) 口腔内崩壊型錠剤及び製造方法
TH43075A (th) สารผสมตามสูตรที่ควบคุมการปลดปล่อยสำหรับการรักษา copd

Legal Events

Date Code Title Description
8364 No opposition during term of opposition